Prospeo
Hero Section BackgroundHero Section Background
Smooth Drug Development, next generation e-CRO in Europe and Asia

Smooth Drug Development, next generation e-CRO in Europe and Asia Revenue

Biotechnology ResearchFlag of USWilmington, Delaware, United States21-50 Employees

$

Smooth Drug Development, next generation e-CRO in Europe and Asia revenue & valuation

Annual revenue$3,500,000
Revenue per employee$72,000
Estimated valuation?$11,200,000
Total fundingNo funding

Key Contacts at Smooth Drug Development, next generation e-CRO in Europe and Asia

Flag of PK

Kamran Khan

Business Development Director

Flag of RU

Alexander Kochiev

Clinical And Regulatory Operations Director

Flag of RU

Alexey Ladutko

Director Of Scientific Department

Flag of US

Dmitry Morozovsky

Ceo

Company overview

HeadquartersSuite 400, Centerville Road, Wilmington, Delaware 19808, US
Phone number+78129130423
Website
NAICS541714
SIC283
Keywords
Pharmacovigilance, CRO, Bioanalytics, Biosimilars, Data Management, E-Pro, Etmf, Epro, Epro Solutions, Clinical Trial Data Management System, Eclinical Outcomes Assessments, Ediary, Electronic Clinical Data Management, Electronic Clinical Outcome Assessments, Electronic Clinical Trial Data Capture, Patient Reported Outcomes, Bioequivalence Studies, Post-Marketing Surveillance, Clinical Trial Services, Clinical Monitoring, Drug Registration, Animal Studies, Clinical Trials Phase I-Iv, Cro In Russia And Cis, Drug Dossier Preparation, Regulatory Support/Cta, Eisf, Cro In Baltic States, Cro In Belarus, Cro In Cis, Cro In Croatia, Cro In Eastern Europe, Cro In Europe, Cro In Hungary, Cro In Russia, Cro In Serbia, Cro In Ukraine, Clinical Trials In Baltic States, Clinical Trials In Eastern Europe, Clinical Trials In Europe, Data Management In Clinical Trials, Clinical Trials In Belarus, Clinical Trials In Cee, Clinical Trials In Cis, Clinical Trials In Russia, Clinical Trials In Ukraine, Clinical Trials In Oncology, Early Phase Clinical Trials, Electronic Diaries, First In Human Clinical Trials
Founded2008
Employees21-50
Socials

Smooth Drug Development, next generation e-CRO in Europe and Asia Email Formats

Smooth Drug Development, next generation e-CRO in Europe and Asia uses 2 email formats. The most common is {last name} (e.g., doe@smoothdd.com), used 95.5% of the time.

FormatExamplePercentage
{last name}
doe@smoothdd.com
95.5%
{2char}
{2char}@smoothdd.com
4.5%

About Smooth Drug Development, next generation e-CRO in Europe and Asia

Smooth Drug Development offers a full range of clinical trial, drug registration and post-marketing services, including consulting, development of registration strategy, conduct of clinical studies and pharmacovigilance in Europe and Asia. We cover wide geography: -EAEA Region -Europe -Latvia -Lithuania -Estonia -Serbia -Slovakia -Hungary -Germany -Spain -Turkiye -India -Pakistan -China Our company implemented the principle of "one stop service" when all activities from planning to product registration are performed consistently under the control of a team of professionals. According to the requirements of ISO 9001:2015, in case of outsourcing of vendors we manage their activities as our ones and are fully responsible for the results. Our Clients are leading pharmaceutical, biotech and R&D companies located in Europe, US, CIS and Asia-Pacific region. We offer drug development services: -Consulting center -Pre-clinical research -Clinical trials -ePRO -eTMF/eISF -Drug registration -Post-marketing surveillance -Pharmacovigilance -Training center We are experts in clinical services: -Project management -Medical writing -Feasibility and site selection -Regulatory support -Data management -Logistics and storage -Clinical monitoring -Medical monitoring -Pharmacovigilance -Bioanalytical and central laboratories -Biomedical statistics -Clinical study report -GCP audit Smooth Drug Development has unique IT solutions for clinical trials which help to speed up clinical trials processes and daily activities. Smooth CTMS includes the following modules: -EDC/eSource/IWRS -eTMF/eISF -ePRO -Learning / QMS -Personal Folder -Clinical Monitoring Smooth Drug Development has been ISO certified: -ISO 9001:2015 Quality Management Systems -ISO 27001:2013 Information Security Management Systems -ISO 22301:2019 Business Continuity Management Systems Please contact us at bd@smoothdd.com or cd@smoothdd.com to learn more about Smooth Drug Development capabilities.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry
Manager
Head

Employees by Department

Smooth Drug Development, next generation e-CRO in Europe and Asia has 21 employees across 8 departments.

Departments

Number of employees

Funding Data

Smooth Drug Development, next generation e-CRO in Europe and Asia has never raised funding before.

Smooth Drug Development, next generation e-CRO in Europe and Asia Tech Stack

Discover the technologies and tools that power Smooth Drug Development, next generation e-CRO in Europe and Asia's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

Cloudflare

CDN

reCAPTCHA

reCAPTCHA

Security

Yandex.Metrika

Yandex.Metrika

Analytics

jQuery

jQuery

JavaScript libraries

Nginx

Nginx

Reverse proxies

Lightbox

Lightbox

JavaScript libraries

PHP

PHP

Programming languages

HSTS

HSTS

Security

Sectigo

Sectigo

SSL/TLS certificate authorities

PWA

PWA

Miscellaneous

lit-element

lit-element

JavaScript libraries

Google Analytics

Google Analytics

Analytics

Frequently asked questions

Smooth Drug Development, next generation e-CRO in Europe and Asia is located in Wilmington, Delaware, US.
You can reach Smooth Drug Development, next generation e-CRO in Europe and Asia at +78129130423.
Smooth Drug Development, next generation e-CRO in Europe and Asia generates an estimated annual revenue of $3,500,000. This revenue figure reflects the company's market position and business performance in its industry.
Smooth Drug Development, next generation e-CRO in Europe and Asia has an estimated valuation of $11,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Smooth Drug Development, next generation e-CRO in Europe and Asia was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.
Smooth Drug Development, next generation e-CRO in Europe and Asia has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles